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Abstract
Previous studies from our laboratory have shown that ethanol consumption results in an increase in hepatocellular S-adenosylho-
mocysteine levels. Because S-adenosylhomocysteine is a potent inhibitor of methylation reactions, we propose that increased intracellular
S-adenosylhomocysteine levels could be a major contributor to ethanol-induced pathologies. To test this hypothesis, hepatocytes isolated
from rat livers were grown on collagen-coated plates in Williams’ medium E containing 5% FCS and exposed to varying concentrations of
adenosine in order to increase intracellular S-adenosylhomocysteine levels. We observed increases in caspase-3 activity following
exposure to adenosine. This increase in caspase activity correlated with increases in intracellular S-adenosylhomocysteine levels and
DNA hypoploidy. The adenosine-induced changes could be significantly attenuated by betaine administration. The mechanism of betaine
action appeared to be via the methylation reaction catalyzed by betaine-homocysteine-methyltransferase. To conclude, our results indicate
that the elevation of S-adenosylhomocysteine levels in the liver by ethanol is a major factor in altering methylation reactions and in
increasing apoptosis in the liver. We conclude that ethanol-induced alteration in methionine metabolic pathways may play a crucial role in
the pathologies associated with alcoholic liver injury and that betaine administration may have beneficial therapeutic effects.
Published by Elsevier Inc.
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1. Introduction
It has been demonstrated that ethanol administration is
linked to increased hepatocyte apoptosis in both clinical
and experimental alcohol-induced liver injury in a variety
of species of animals including rats, mice and minipigs [1–
13]. Although much progress has been made in under-
standing the role of critical factors that may be involved,
such as cytokines and oxidative stress, there is still no
unified hypothesis to explain the pathogenesis of alcohol-
induced apoptosis of hepatocytes.
Our laboratory and others have established that multiple
steps in the methionine metabolic cycle (Fig. 1) are
affected in the liver by ethanol consumption [14–16].
The earliest studies conducted in our laboratory showed
that a major defect elicited by ethanol consumption
appears to be the inhibition of methionine synthase
(MS) activity, resulting in impaired remethylation of
homocysteine to form methionine [3,17,18]. This defect
ultimately results in an increased generation of the poten-
tially toxic agent, homocysteine, which is released from the
liver [12–14,19–21]. Ethanol consumption also results in
increased hepatocellular levels of S-adenosylhomocys-
teine (SAH) [3,21,22]—a product of methyl transfer reac-
tions involving S-adenosylmethionine (SAM) and the
metabolic precursor of homocysteine and adenosine. Since
the reaction that converts SAH to homocysteine and ade-
nosine (catalyzed by SAH hydrolase) is reversible and
proceeds toward hydrolysis only if the products are
removed [15], the accumulation of homocysteine follow-
www.elsevier.com/locate/biochempharm
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ing ethanol exposure drives SAH hydrolase to catalyze the
energetically favorable reverse reaction resulting in
increased SAH generation [22].
In recent years there have been reports of increased
intracellular SAH levels inducing apoptosis in many dif-
ferent cell types [23–29]. Therefore, we put forth the
hypothesis that increased intracellular SAH generation
may be responsible for hepatocyte apoptosis seen after
ethanol administration. To test our hypothesis, we needed
to achieve elevated intracellular SAH levels in hepatocytes
without ethanol exposure. We accomplished this under-
taking by exploiting the unique characteristic of the
enzyme SAH hydrolase—the only enzyme involved in
SAH catabolism. Since SAH hydrolase catalyzes the
reversible hydrolysis to adenosine and homocysteine with
equilibrium of the reaction favoring the synthesis of SAH
[30,31], altering the levels of its products (adenosine and/or
homocysteine) has been shown to play a critical role in the
control of tissue levels of SAH [24–26,32]. Therefore in
this study, hepatocytes were exposed to varying concen-
trations of adenosine in order to promote the generation of
SAH in order to increase intracellular SAH levels. Follow-
ing exposure to adenosine, indices of apoptosis were
determined.
In addition, our laboratory has also been interested in the
therapeutic properties of betaine, a naturally occurring
trimethylglycine that principally functions as an osmolyte
and methyl donor [33]. As an osmolyte, betaine protects
cells, proteins and enzymes from environmental stress,
including extreme temperature, high salinity and low water
content. As a methyl donor, betaine participates in the
methionine cycle, and by remethylating homocysteine via
betaine-homocysteine-methyltransferase (BHMT) has
been shown to alleviate ethanol-induced changes in intra-
cellular SAH levels [22].
Therefore, the objective of this study was: (1) to induce
elevated intracellular SAH levels in hepatocytes without
ethanol intervention and observe its effect on hepatocyte
apoptosis and (2) to evaluate the therapeutic affect of
betaine on hepatocyte apoptosis under these conditions.
2. Materials and methods
2.1. Animals
Male Wistar rats (Charles River Laboratories, Wilming-
ton, MA) weighing 150–175 g were used. The animals
were fed the Purina 5001 diet (Ralston Purina, St. Louis,
MO) and housed at the Omaha Veterans Affairs Medical
Center Animal Research Facility. The care and the use of
the rats was approved by the Institutional Animal Care and
Use Committee in accordance with the guidelines of the
Institutional Care and Use Committee of the National
Institute on Drug Abuse, National Institutes of Health,
and the Guide for the Care and Use of Laboratory Animals
[34].
2.2. Hepatocyte isolation and experimental design
Hepatocytes were obtained from the livers of the rats by
a modified collagenase-perfusion technique as previously
described [22]. Viabilities of the different cell populations
were determined by trypan blue exclusion, and only cell
preparations attaining a viability of >90% were used.
Isolated hepatocytes were plated (4.5 million viable
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Fig. 1. Methionine metabolic pathway in the liver. Using ATP as a substrate, methionine adenosyltransferase (MAT) converts methionine to S-adenosyl-
methionine (SAM), which then serves as a methyl-group donor substrate for methyltransferases. The other product of methyltransferase reaction S-
adenosylhomocysteine (SAH) is hydrolyzed to adenosine and homocysteine by S-adenosylhomocysteine hydrolase (SAHH). The thermodynamic of this
reaction favors the formation of SAH if the products are not removed. The methionine cycle is completed when homocysteine is remethylated back to
methionine by B12-dependent methionine synthase (MS) using 5-methyltetrahydrofolate (CH3THF) as substrate. The latter is generated by methylene
tetrahydrofolate reductase (MTHFR). Homocysteine can also be remethylated to methionine by betaine homocysteine methyltransferase (BHMT) with the
formation of dimethylglycine (DMG). Homocysteine can also be catabolized through the transulfuration pathway initiated by B6-dependent cystathionine b-
synthase (CBS) to generate glutathione (GSH).
cells/dish) on 10 mg collagen IV-coated 100 mm culture
dishes in Williams’ medium E supplemented with anti-
biotics and 5% FCS. After 2 h of plating at 37 8C in a
humidified atmosphere of 95% O2/5% CO2, the medium
and unattached cells were removed and replaced with
10 ml of serum-supplemented Williams’ medium E con-
taining 0–1 mmol/L adenosine. In some dishes, 2 mmol/L
betaine and/or 10 mmol/L dimethylglycine (DMG) were
added just before addition of adenosine. DMG is the
demethylated product of betaine formed by the BHMT
catalyzed reaction and is shown to be a potent feedback
inhibitor of porcine, rat and human BHMT [35]. Betaine
was obtained from Danisco USA Incorporated, Ardsley,
NY. All other chemicals were obtained from Sigma–
Aldrich Corp., St. Louis, MO.
After overnight treatment, the following analyses were
done.
Extent of apoptosis was evaluated by the measurements
of the following markers of apoptosis:
Caspase-3 activation assay: Treated hepatocytes were
lysed and then assayed for specific caspase activity follow-
ing manufacturers’ instructions using commercially avail-
able caspase-3 Ac-DEVD-AMC fluorogenic substrate (BD
Biosciences, San Diego, CA). Caspase activity was evalu-
ated by measuring the release of AMC (7-Amino-4-methyl-
coumarin) obtained by the cleavage of the defined synthetic
peptide sequence by caspase-3 using a Perkin-Elmer Lumi-
nescence Spectrophotometer LS 50B. Free AMC obtained
from Sigma–Aldrich, St. Louis, MO was used as the stan-
dard. The caspase-3 activity was expressed as pmoles of
AMC produced per mg hepatocyte lysate protein.
DNA-fragmentation analysis: The treated hepatocytes
were harvested, fixed in ethanol and incubated with
DNA staining solution (RNAase A/propidium iodide
mixture) [36]. After incubation, the nuclear DNA con-
tent in hepatocytes was evaluated using a FACSCalibur
(excitation, 488; emission 575 nm; Becton Dickinson,
San Jose, CA) flow cytometer. DNA fluorescence pulse
processing was used to discriminate between single cells
and aggregates of cells by evaluating the FL2-width
versus FL2-area scatter plot. Light scatter gating was
used to eliminate smaller debris from analysis. DNA
content was displayed on a linear scale. Apoptosis was
determined by DNA hypoploidy quantification by iden-
tifying the percentage of cells in the sub-G1 hypodiploid
zone of the DNA fluorescent cytogram using Modfit
analysis program obtained from Varity software house
(VSH, Topsham, ME). Data was collected from
10,000 nuclei/assay.
Measurement of cell necrosis: Cytotoxicity measure-
ments were done by determining the release of lactate
dehydrogenase (LDH) in the culture medium. The leakage
of LDH was measured by incubating a volume of the
medium with NADH (0.2 mmol/L) and pyruvic acid
(0.4 mmol/L) diluted in phosphate buffer as described
[37] and expressed as % LDH release over controls.
SAH levels: Hepatocyte pellets were homogenized in
0.5 mol/L HClO4, and the filtered acid extracts directly
subjected to HPLC analysis for the determination of
hepatocellular SAH levels following the procedure of Fu
et al. [38] as detailed in our publication [22].
Homocysteine levels: Hepatocyte pellets and the condi-
tioned media were subjected to HPLC analysis for the
determination of total (hepatocellular + secreted) homo-
cysteine [39] as detailed in our publication [22].
Statistical analysis: Data were analyzed by ANOVA,
followed by Student’s Newman–Keuls post hoc test. A P
value <0.05 was regarded as statistically significant.
3. Results
Hepatocytes cultured in vitro overnight on collagen IV
matrix in serum-supplemented Williams’ medium E main-
tained their normal phenotype with flattened morphology.
In dishes with adenosine supplementation, the hepatocytes
showed changes in morphology to a more rounded appear-
ance.
The caspases are a family of cysteine-aspartic acid-
specific proteases involved in the cleavage of cellular
substrates that ultimately leads to apoptosis. This family
contains some members that act as signal transduction
molecules, while other members carry out the executioner
function in the process of apoptosis. The measurement of
executioner caspase activation (caspase-3) has become a
widely accepted marker of the process of apoptosis. We
observed that incubation with increasing concentrations of
adenosine induced a dose-dependent increase in caspase-3
activity in hepatocytes (Fig. 2). An 8–10-fold increase in its
activity was seen with the highest dose of adenosine tested
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Fig. 2. Effect of adenosine and betaine on caspase-3 activity in rat
hepatocytes. Isolated hepatocytes from chow-fed rats were seeded on
collagen IV-coated 100 mm petri plates at 4.5 million cells/plate in Wil-
liams’ medium E supplemented with 5% FCS. After 2 h of plating, the
unattached cells were removed and replaced with serum-supplemented
Williams’ medium E containing varying amounts of adenosine (0–
1 mmol/L) in the presence and absence of 2 mmol/L betaine. After over-
night incubation, caspase-3 activity was determined in the cellular lysate.
Data represent mean of five determinations. *P < 0.05 as compared to
betaine-untreated samples.
(1 mmol/L). When betaine at 2 mmol/L was added along
with adenosine, a 40–50% decrease in adenosine-induced
caspase-3 activity increase was seen.
Apoptosis was also quantified by determining the extent
of internucleosomal DNA cleavage or DNA-fragmentation
by subjecting the treated hepatocytes to flow cytometric
analysis following PI staining. By this methodology, the
apoptotic nuclei stained with PI appeared as a broad
hypodiploid peak that was easily distinguishable from
viable nuclei with diploid DNA. DNA-fragmentation or
percent apoptosis determined from the cytograms obtained
from one representative experiment is shown in Fig. 3. The
average of the percent apoptosis obtained from five such
independent experiments are shown as Table 1. We
observed low percent apoptosis to the extent of
2.6  0.5% in freshly isolated hepatocytes. There was a
slight enhancement of percent apoptosis in hepatocytes
cultured overnight under basal conditions. Treatment with
0.75 mmol/L adenosine led to a 3-fold increase in apop-
tosis as compared to controls. Co-incubation with betaine
led to a significant decrease in DNA-fragmentation in
adenosine-exposed hepatocytes to near control levels
(Fig. 3). These flow cytometric results correlated with
the results obtained for caspase activities (r2 = 0.91,
P < 0.05).
Since one pathway of intracellular adenosine metabo-
lism relates to increased intracellular SAH levels, these
levels were determined in hepatocyte pellets after treat-
ments. We observed that when rat hepatocytes were incu-
bated with varying amounts of adenosine, a corresponding
increase in intracellular SAH levels was seen (Fig. 4). A
10-fold increased level was observed with 1 mmol/L ade-
nosine treatment. While adenosine treatment increased
SAH levels, the presence of adenosine decreased the total
homocysteine levels. The homocysteine values (mean
 S.E.M.) for controls were 675  70 pmol/mg DNA com-
pared to values for 0.25, 0.5, 0.75 and 1 mmol/L adenosine
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Fig. 3. Flow cytograms of DNA-fragmentation in hepatocytes: effects of adenosine and betaine. Rat hepatocytes seeded on collagen IV-coated 100 mm petri
plates in Williams’ medium E supplemented with 5% FCS were treated overnight in the presence and absence of 0.75 mmol/L adenosine and 2 mmol/L betaine.
Following treatment, the hepatocytes were harvested, fixed in ethanol, incubated with DNA staining solution and the nuclear DNA content evaluated using a
FACSCalibur flow cytometer. Apoptosis was determined by DNA hypoploidy quantification by identifying the percentage of cells in the sub-G1 hypodiploid
zone (recognized at the left of the major peak, labeled M1 in the cytogram) using Modfit analysis program obtained from Varity software house (VSH, Topsham,
ME). The cytograms and the percent apoptosis are from one of five independent experiments, all of which had similar results.
Table 1
Effects of adenosine and betaine on hepatocyte apoptosis
Treatment Percent apoptosisa
Before incubation 2.6  1.9a
After overnight incubation with
Media alone 7.4  2.2a
+Betaine (2 mmol/L) 4.2  1.2a
+Adenosine (0.75 mmol/L) 19.2  4.2b
+Adenosine (0.75 mmol/L) +
betaine (2 mmol/L)
8.6  3.1a
Rat hepatocytes, either freshly isolated or following overnight culture in the
presence and absence of 0.75 mmol/L adenosine and 2 mmol/L betaine,
were fixed in ethanol, incubated with DNA staining solution and the nuclear
DNA content in hepatocytes evaluated using a FACSCalibur (excitation,
488; emission 575 nm) flow cytometer. Apoptosis was determined by DNA
hypoploidy quantification by identifying the percentage of cells in the sub-
G1 hypodiploid zone of the DNA fluorescent cytogram using Modfit
analysis program obtained from Varity software house (VSH, Topsham,
ME).
a Values listed are means  S.E.M. for five independent experiments.
Values not sharing a common letters (a and b) are significantly different by
ANOVA; P < 0.01.
of 430  122, 351  174, 303  177 and 292  112 pmol/
mg DNA, respectively (P < 0.05).
We further observed that adenosine-induced increases in
SAH levels were significantly decreased by 40–50% fol-
lowing co-incubation with betaine, indicating that betaine
may be protecting against adenosine-induced apoptosis
presumably via BHMT catalyzed methylation reactions
to decrease SAH levels.
Therefore, to evaluate whether the protective mechan-
ism of betaine incubation is via methylation reactions,
hepatocytes were simultaneously also exposed to DMG, a
potent inhibitor of BHMT activity. Addition of DMG alone
to control hepatocytes or adenosine-treated hepatocytes
resulted in a small increase in caspase-3 activity (Fig. 5).
More importantly, it attenuated the protective effect of
betaine under basal as well as under adenosine-supple-
mented condition.
No significant changes in LDH release under any experi-
mental conditions were observed (data not shown).
4. Discussion
This study was conducted with the goal to causally link
elevated intracellular SAH levels seen in hepatocytes
following ethanol consumption to alcoholic apoptosis
observed in a variety of animal species. In this study,
we conducted our experiments on isolated hepatocytes
obtained from chow-fed rats rather than ethanol-fed rats
because we wanted hepatocytes without any previous
alterations in pathways of methionine metabolism. These
naı¨ve hepatocytes were then exposed in vitro to agents that
are known to increase intracellular SAH levels by exploit-
ing the unique characteristic of the enzyme, SAH hydro-
lase, which catalyzes the reverse hydrolysis of SAH to
adenosine and homocysteine. Incubations with SAH-
hydrolase inhibitor, or under conditions of excess adeno-
sine and homocysteine either added alone or in combina-
tion have all been shown to generate increased intracellular
SAH [24–26,32]. But in our study, we did not use homo-
cysteine as an agent to achieve increased intracellular SAH
levels but instead focused on adenosine. This agent ele-
vated intracellular SAH without increasing either hepato-
cellular or secreted homocysteine levels, thus facilitating
the effects of elevated intracellular SAH to be distin-
guished from those implicated via elevated homocys-
teine-induced ER stress [12,13].
The data in this study indicate that increased intracel-
lular SAH functions as a physiological modulator of
hepatocyte apoptosis. Our study also corroborates a recent
publication that implicated increased intracellular SAH
levels with hepatotoxicity [40] and supports of the concept
that removal of intracellular SAH is a potential therapeutic
option. Although the message is similar, this recent pub-
lished study differs from ours in that no toxicity was
observed in HepG2 on exposure to agents, such as ade-
nosine, homocysteine and 3-deaza-adenosine (a SAH
hydrolase inhibitor) that are known to increase intracellular
SAH levels [40]. These HepG2 cells with elevated SAH
levels, however, showed increased sensitivity to TNFa
toxicity [40]. The disparity between their study and our
study may be due to the fact that Song et al. conducted their
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Fig. 4. Effect of adenosine and betaine on intracellular S-adenosylhomo-
cysteine (SAH) levels. Isolated hepatocytes from chow-fed rats were seeded
on collagen IV-coated 100 mm petri plates at 4.5 million cells/plate in
Williams’ medium E supplemented with 5% FCS. After 2 h of plating, the
unattached cells were removed and replaced with serum-supplemented
Williams’ medium E containing varying amounts of adenosine (0–
1 mmol/L) in the presence and absence of 2 mmol/L betaine. Following
overnight incubations, the intracellular SAH levels were determined. Data
represent mean of three determinations. Values not sharing a common
subscript letter are significantly different by ANOVA; P < 0.05.
Fig. 5. Effect of adenosine, betaine and dimethylglycine (DMG) on cas-
pase-3 activity. Isolated hepatocytes from chow-fed rats were seeded on
collagen IV-coated 100 mm petri plates at 4.5 million cells/plate in Wil-
liams’ medium E supplemented with 5% FCS. After 2 h of plating, the
unattached cells were removed and replaced with serum-supplemented
Williams’ medium E in the presence and absence of 0.75 mmol/L adeno-
sine, 2 mmol/L betaine and 10 mmol/L DMG. After overnight incubation,
caspase-3 activity was determined in the cellular lysate. Data represent
mean of five determinations. Values not sharing a common subscript letter
are significantly different by ANOVA; P < 0.05.
experiments in a hepatoma-derived cell line and not with
hepatocytes in primary culture that were employed in the
current study. Recent reports from our laboratory have also
shown that exposure to 7-deaza-adenosine (another potent
SAH hydrolase inhibitor) alone also induces apoptosis in
rat hepatocytes in primary cultures [41].
We further show that betaine confers protection against
apoptosis. This evidence is based on the following obser-
vations. First, addition of adenosine that increase intracel-
lular SAH levels, induce increases in activity of effector
caspase (caspase-3) as well as cause increases in DNA-
fragmentation. A linear correlation existed between SAH
levels and caspase-3 activity (r2 = 0.91; P < 0.01). Second,
betaine by decreasing intracellular SAH by virtue of
remethylating homocysteine, results in significant attenua-
tion in adenosine-induced increased caspase activities and
DNA-fragmentation.
In our hands, the minimum concentration of adenosine
required to observe increases in intracellular SAH levels in
cultured hepatocytes was 0.5 mmol/L, which was also the
minimum concentration required to observe increases in
caspases activation. Earlier studies had employed much
lower amounts of adenosine (50 mmol/L) in order to
achieve elevated intracellular SAH and induce toxicity
in cultured mouse lymphoblasts [23]. It is possible that
the use of different cell-types or animal sources may be
responsible for the inconsistency observed between the two
studies. This speculation is based on the fate of adenosine
metabolism that relates not only to homocysteine metabo-
lism and the ability of adenosine to form a stable complex
with SAH hydrolase to inhibit SAH hydrolase activity, but
also to the metabolism of adenosine within seconds by
adenosine deaminase (ADA) to inosine or its phosphor-
ylation by adenosine kinase to form 50AMP. It is likely that
lower adenosine concentration could induce toxicity in
lymphoblasts in previous studies because these cells were
isolated from ADA-deficient mice and therefore were
probably more susceptible to lower adenosine concentra-
tions because of its inhibited metabolism to inosine.
More recent studies using various cell types that impli-
cate increased adenosine toxicity via increased SAH levels
have employed comparable adenosine concentrations as
used by us [24,26–29,42]. The mechanism of action of
adenosine appears to be via its ability to act as a substrate
for as well as an inhibitor of SAH hydrolase thereby
elevating intracellular SAH.
Further implicating the role of elevated SAH as one of
the principle factors responsible for apoptosis were the
experiments conducted with betaine supplementation.
Betaine by virtue of decreasing elevated SAH levels as
shown in this study as well as in our previous publication
[22], also significantly attenuated-induced apoptosis.
Additional experiments conducted with the inclusion of
excess DMG—a potent feedback inhibitor of porcine, rat
and human BHMT [35]—demonstrated the mechanism of
action of betaine. We observed that DMG added in 5-fold
excess of the concentration of betaine partially blocked the
protective effect of betaine on adenosine-induced apopto-
sis. This reaffirmed that the protective effect of betaine was
primarily via methyl-group transfer reaction catalyzed by
BHMT that alleviates the increased intracellular SAH
levels by remethylating homocysteine.
The protective effect of betaine in preventing hepatocyte
apoptosis has also been corroborated by reports from dif-
ferent laboratories in which apoptosis was induced by
various conditions including hypertonicity [43], bile salts
[44] and perfusion–reperfusion liver injury [45]. It is not
known whether these experimental manipulations of hyper-
tonicity, bile salts exposure and perfusion–reperfusion
injury also result in alterations in methionine metabolic
pathways, especially elevations of intracellular SAH levels.
Betaine has also been shown to protect against alcoholic
liver injury [12,13,20,22,46–49], prevent carbon tetra-
chloride-induced liver injury [50] as well as to consider-
ably decrease indices of steatosis in NASH patients
[51,52]. In addition, betaine has been effectively used as
a treatment regimen for patients with inherited genetic
disorders of hyperhomocysteinemia such as cystathionine
b-synthase deficiency and methylene tetrahydrofolate
reductase deficiency [53]. Although the untreated patients
with these deficiencies always present with hepatic
abnormalities, of particular interest to us is the generation
of animal models with these genetic deficiencies where a
more detailed biochemical analysis has been done. The
livers of these animals have high SAH levels [54–56], show
liver injury [57] and betaine administration appears to
reverse these biochemical alterations [57].
Our future studies are aimed at elucidating the mechan-
ism by which elevated intracellular SAH promotes apop-
tosis. Since the homeostatic levels of SAH are critically
important on account of SAH being a potent product-
inhibitor of many SAM-dependent methyltransferases
[58], we postulate a critical role of one or more liver
methyltransferases in preventing hepatocyte apoptosis.
Recent studies have shown that the carboxyl methylation
reaction of small GTPases is a crucial activation step that
facilitates these proteins to participate in anti-apoptotic
signaling pathways [59]. We speculate that inhibition of
the critical methyltransferase (such as isoprenyl cysteine
methyltransferase) by elevated intracellular SAH levels
may be responsible for adenosine-induced apoptosis in
hepatocytes.
To conclude, we have data that provides a definite link
between elevated intracellular SAH and increased hepa-
tocyte apoptosis and presents a therapeutic approach of
betaine as a modality to prevent alcoholic apoptosis. These
results indicate that the elevation of SAH levels in the liver
by ethanol appears to be a major factor in altering methy-
lation reactions and in increasing apoptosis in the liver.
Considering the link between hepatocyte apoptosis and
liver fibrosis [60], inhibition of hepatocyte apoptosis by
betaine may also be an anti-fibrotic therapeutic strategy.
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